Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

BeiGene Signs Up Industry Veterans for Scientific Advisory Board

publication date: Aug 20, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
BeiGene, Ltd., a Beijing pharma formed in 2010, announced a Scientific Advisory Board that includes an international list of experts with experience in oncology drugs. The SAB is comprised of: Neal Rosen, MD, PhD; David Schenkein, MD; Charles Sawyers, MD; Xiaodong Wang, PhD; and Steve Young, PhD. BeiGene discovers its own cancer drug candidates and in-licenses molecules that are close to clinical stage for China development. It calls itself a proof-of-concept company. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...